Date posted
Funding Agency
(Funded by the National Institutes of Health)
Researchers have invented a new ultrasensitive diagnostic device that could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions and better outcomes for patients. The “lab-on-a-chip” for “liquid biopsy” analysis detects exosomes — tiny parcels of biological information produced by tumor cells to stimulate tumor growth or metastasize.